MEpedia - User contributions [en]

Brett Lidbury

2018-05-14T05:40:53Z

Brett Lidbury:Corrections

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==ME/CFS Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (University of Melbourne), La Trobe University and Universidad del Rosario, Bogota (School of Medicine and Health Sciences). Via these collaborations we are gathering data on potential immune serum markers (see [[Activin B]]), mitochondrial function and metabolomics, as well as genetics, with the ANU group applying computational methods, for example machine learning, to interrogate these results as a systems biology investigation. A strength at the ANU is also the assessment of pathology and clinical data to increase diagnostic prediction, while developing rules to simplify decision-making for patient assessment.

The ME/CFS project for the validation of Activin markers is funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, and projects concerning genetic analyses are funded by [[ME Research UK]].<ref>http://www.meresearch.org.uk/</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2018, Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection<ref name="Richardson, 2018"/>
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Linked-In
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube (Pending)

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
<ref name="Richardson, 2018">
{{Citation
| last1 = Richardson | first1 = Alice | authorlink1 =
| last2 = Lewis | first2 = Donald | authorlink2 = Donald Lewis
| last3 = Kita | first3 = Badia | authorlink3 =
| last4 = Ludlow | first4 = Helen | authorlink4 =
| last5 = Groome | first5 = Nigel | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| last8 = Lidbury | first8 = Brett | authorlink8 = Brett Lidbury
| title = Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
| journal = Journal of Translational Medicine | volume = 16 | issue = | page = 97
| date = 2018
| pmid =
| doi = 10.1186/s12967-018-1473-z
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-14T05:38:56Z

Brett Lidbury:Typo

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (University of Melbourne), La Trobe University and Universidad del Rosario, Bogota (School of Medicine and Health Sciences). Via these collaborations we are gathering data on potential immune serum markers (see [[Activin B]]), mitochondrial function and metabolomics, as well as genetics, with the ANU group applying computational methods, for example machine learning, to interrogate these results as a systems biology investigation. A strength at the ANU is also the assessment of pathology and clinical data to increase diagnostic prediction, while developing rules to simplify decision-making for patient assessment.

The ME/CFS project for the validation of Activin markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, and the project concerning genetic analyses are funded by [[ME Research UK]].<ref>http://www.meresearch.org.uk/</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2018, Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection<ref name="Richardson, 2018"/>
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Linked-In
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube (Pending)

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
<ref name="Richardson, 2018">
{{Citation
| last1 = Richardson | first1 = Alice | authorlink1 =
| last2 = Lewis | first2 = Donald | authorlink2 = Donald Lewis
| last3 = Kita | first3 = Badia | authorlink3 =
| last4 = Ludlow | first4 = Helen | authorlink4 =
| last5 = Groome | first5 = Nigel | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| last8 = Lidbury | first8 = Brett | authorlink8 = Brett Lidbury
| title = Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
| journal = Journal of Translational Medicine | volume = 16 | issue = | page = 97
| date = 2018
| pmid =
| doi = 10.1186/s12967-018-1473-z
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-14T05:34:27Z

Brett Lidbury:Typo

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne), La Trobe University and Universidad del Rosario, Bogota (School of Medicine and Health Sciences). Via these collaborations we are gathering data on potential immune serum markers (see [[Activin B]]), mitochondrial function and metabolomics, as well as genetics, with the ANU group applying computational methods, for example machine learning, to interrogate these results as a systems biology investigation. A strength at the ANU is also the assessment of pathology and clinical data to increase diagnostic prediction, while developing rules to simplify decision-making for patient assessment.

The ME/CFS project for the validation of Activin markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, and the project concerning genetic analyses are funded by [[ME Research UK]].<ref>http://www.meresearch.org.uk/</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2018, Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection<ref name="Richardson, 2018"/>
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Linked-In
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube (Pending)

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
<ref name="Richardson, 2018">
{{Citation
| last1 = Richardson | first1 = Alice | authorlink1 =
| last2 = Lewis | first2 = Donald | authorlink2 = Donald Lewis
| last3 = Kita | first3 = Badia | authorlink3 =
| last4 = Ludlow | first4 = Helen | authorlink4 =
| last5 = Groome | first5 = Nigel | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| last8 = Lidbury | first8 = Brett | authorlink8 = Brett Lidbury
| title = Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
| journal = Journal of Translational Medicine | volume = 16 | issue = | page = 97
| date = 2018
| pmid =
| doi = 10.1186/s12967-018-1473-z
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-14T05:19:20Z

Brett Lidbury:Update

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne), La Trobe University and Universidad del Rosario, Bogota (School of Medicine and Health Sciences). Via these collaborations we are gathering data on potential immune serum markers (see [[Activin B]]), mitochondrial function and metabolomics, as well as genetics, with the ANU group applying computational methods, for example machine learning, to interrogate these results as a systems biology investigation. A strength at the ANU is also the assessment of pathology and clinical data to increase diagnostic prediction, while developing rules to simplify decision-making for patient assessment.

The CFS/ME projects for validation of immune markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, and the ME/CFS project concerning genetic analyses are funded by [[ME Research UK]].<ref>http://www.meresearch.org.uk/</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2018, Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection<ref name="Richardson, 2018"/>
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Linked-In
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube (Pending)

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
<ref name="Richardson, 2018">
{{Citation
| last1 = Richardson | first1 = Alice | authorlink1 =
| last2 = Lewis | first2 = Donald | authorlink2 = Donald Lewis
| last3 = Kita | first3 = Badia | authorlink3 =
| last4 = Ludlow | first4 = Helen | authorlink4 =
| last5 = Groome | first5 = Nigel | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| last8 = Lidbury | first8 = Brett | authorlink8 = Brett Lidbury
| title = Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
| journal = Journal of Translational Medicine | volume = 16 | issue = | page = 97
| date = 2018
| pmid =
| doi = 10.1186/s12967-018-1473-z
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-14T05:14:15Z

Brett Lidbury:Typo

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne), La Trobe University and Universidad del Rosario, Bogota (School of Medicine and Health Sciences). Via these collaborations we are gathering data on potential immune serum markers (see [[Activin B]]), mitochondrial function and metabolomics, as well as genetics, with the ANU group applying computational methods, for example machine learning, to interrogate these results as a systems biology investigation. A strength at the ANU is also the assessment of pathology and clinical data to increase diagnostic prediction, while developing rules to simplify decision-making for patient assessment.

The CFS/ME projects for validation of immune markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, and the ME/CFS project concerning genetic analyses are funded by [[ME Research UK]].<ref>http://rsph.anu.edu.au/people/academics/associate-professor-brett-lidbury#acton-tabs-link--tabs-person_tabs-middle-1</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2018, Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection<ref name="Richardson, 2018"/>
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Linked-In
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube (Pending)

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
<ref name="Richardson, 2018">
{{Citation
| last1 = Richardson | first1 = Alice | authorlink1 =
| last2 = Lewis | first2 = Donald | authorlink2 = Donald Lewis
| last3 = Kita | first3 = Badia | authorlink3 =
| last4 = Ludlow | first4 = Helen | authorlink4 =
| last5 = Groome | first5 = Nigel | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| last8 = Lidbury | first8 = Brett | authorlink8 = Brett Lidbury
| title = Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
| journal = Journal of Translational Medicine | volume = 16 | issue = | page = 97
| date = 2018
| pmid =
| doi = 10.1186/s12967-018-1473-z
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-14T04:51:51Z

Brett Lidbury:Ref updates

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), and in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne), La Trobe University and Universidad del Rosario, Bogota (School of Medicine and Health Sciences). Via these collaborations we are gathering data on potential immune serum markers (see [[Activin B]]), mitochondrial function and metabolomics, as well as genetics, with the ANU group applying computational methods, for example machine learning, to interrogate these results as a systems biology investigation. A strength at the ANU is also the assessment of pathology and clinical data to increase diagnostic prediction while developing rules to simplify decision-making for patients.

The CFS/ME projects for validation of immune markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, and the ME/CFS project concerning genetic analyses are funded by [[ME Research UK]].<ref>http://jcsmr.anu.edu.au/groups/groups/lidbury-group</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2018, Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection<ref name="Richardson, 2018"/>
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Linked-In
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube (Pending)

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
<ref name="Richardson, 2018">
{{Citation
| last1 = Richardson | first1 = Alice | authorlink1 =
| last2 = Lewis | first3 = Donald | authorlink2 =
| last3 = Kita | first3 = Badia | authorlink3 =
| last4 = Ludlow | first4 = Helen | authorlink4 =
| last5 = Groome | first5 = Nigel | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| last8 = Lidbury | first8 = Brett | authorlink8 = Brett Lidbury
| title = Weighting of orthostatic intolerance time measurements with standing difficulty score stratifies ME/CFS symptom severity and analyte detection
| journal = Journal of Translational Medicine | volume = 16 | issue = | page = 97
| date = 2018
| pmid =
| doi = 10.1186/s12967-018-1473-z
</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-14T04:15:47Z

Brett Lidbury:Update collabs

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Population Health (Research School of Population Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his colleagues are conducting Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne (Donvale, VIC 3111), and in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne, Australia), La Trobe University and John Curtin School of Medical Research. The CFS/ME projects for validation of immune markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation and the CFS/ME projects for genetic analyses are funded by [[ME Research UK]].<ref>http://jcsmr.anu.edu.au/groups/groups/lidbury-group</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2017, Activin B is a novel [[biomarker]] for [[ME/CFS|chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)]] diagnosis: a cross sectional study<ref name=" Lidbury, 2017"/>
*2014, Comorbidity of [[postural orthostatic tachycardia syndrome]] and [[chronic fatigue syndrome]] in an Australian cohort.<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Twitter
*Facebook
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>
<ref name=" Lidbury, 2017">
{{Citation
| last1 = Lidbury | first1 = Brett | authorlink1 = Brett Lidbury
| last2 = Badia | first2 = Kita | authorlink2 =
| last3 = Lewis | first3 = Donald | authorlink3 =
| last4 = Hayward | first4 = Susan | authorlink4 =
| last5 = Ludlow | first5 = Helen | authorlink5 =
| last6 = Hedger | first6 = Mark | authorlink6 =
| last7 = de Kretser | first7 = David | authorlink7 =
| title = Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study
| journal = Journal of Translational Medicine | volume = | issue = | page =
| date = 2017
| pmid =
| doi = 10.1186/s12967-017-1161-4
}}
</ref>
</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-09T06:50:27Z

Brett Lidbury:Typo

Brett Lidbury

2018-05-09T06:48:56Z

Brett Lidbury:Affiliation

Brett Lidbury

2018-05-09T06:47:41Z

Brett Lidbury:Awards

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Public Health (Research School of Public Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, leading to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]]. Our work is entirely focused on human biology and pathology, without the requirement to develop an animal model.<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref>

==CFS/ME Research==
Dr Lidbury and his students are conducting Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne, and in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne, Australia) and John Curtin School of Medical Research. The CFS/ME projects for validation of immune markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation and the CFS/ME projects for genetic analyses are funded by [[ME Research UK]].<ref>http://jcsmr.anu.edu.au/groups/groups/lidbury-group</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>
* Fellowship to the Faculty of Science, The Royal College of Pathologists of Australasia.

==Notable studies==
*2014, Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Twitter
*Facebook
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]

Brett Lidbury

2018-05-09T06:42:40Z

Brett Lidbury:Update institutional details

'''Brett A. Lidbury''', B.Sc. (Hons), Ph.D., is an Associate Professor with the National Centre for Epidemiology and Public Health (Research School of Public Health), College of Health and Medicine at the Australian National University. His areas of expertise are medical virology,
innate immunity, and biostatistics. Research interests include improving the efficacy of diagnostic pathology and biomarker pattern discovery, particularly in relation to ME/CFS and infectious diseases. Earlier research activity was interested in Ross River virus (RRV) pathogenesis, which as an Australian viral suspect in long-term fatigue, lead to current endeavours for ME/CFS [[chronic fatigue syndrome]]/[[myalgic encephalomyelitis]] (CFS/ME).<ref>https://researchers.anu.edu.au/researchers/lidbury-ba</ref> Our work is entirely focused on human biology and pathology, without the requirement to develop and animal model.

==CFS/ME Research==
Dr Lidbury and his students are conducting Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) studies that are ongoing with research participants recruited and assessed by CFS Discovery in Melbourne, and in collaboration with the Hudson Research Institute, Paranta Biosciences, Bio21 Institute (Melbourne, Australia) and John Curtin School of Medical Research. The CFS/ME projects for validation of immune markers are funded by the Judith Jane Mason & Harold Stannett Williams Memorial Foundation and the CFS/ME projects for genetic analyses are funded by [[ME Research UK]].<ref>http://jcsmr.anu.edu.au/groups/groups/lidbury-group</ref>

==Awards==
* Nominee for 2016 ACT Scientist of the Year<ref>https://meaustralia.net/2016/07/11/me-microbiome-scientist-nominated-as-act-scientist-of-the-year/comment-page-1/</ref>

==Notable studies==
*2014, Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.<ref name="Reynolds, 2014"/>

==Talks & interviews==

==Online presence==
*PubMed
*Twitter
*Facebook
*[https://researchers.anu.edu.au/researchers/lidbury-ba Website]
*YouTube

==Learn more==
*Wikipedia
*Institution
*2016, [http://www.meaction.net/2016/04/05/meet-the-scientists-dr-brett-lidbury/ Meet the scientists - Dr Brett Lidbury]

==See also==
*[[Australia]]

==References==
<references>
<ref name="Reynolds, 2014">
{{Citation
| last1 = Reynolds | first1 = GK | authorlink1 =
| last2 = Lewis | first2 = Donald P | authorlink2 = Donald Lewis
| last3 = Richardson | first3 = Alice M | authorlink3 =
| last4 = Lidbury | first4 = Brett A | authorlink4 = Brett Lidbury
| title = Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
| journal = Journal of Internal Medicine | volume = 275 | issue = 4 | page = 409-17
| date = 2014
| doi = 10.1111/joim.12161
}}
</ref>

</references>

[[Category:Researchers]]
[[Category:Australia researchers]]